This inventor holds 1 USPTO granted patent. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Kathrin Balz: Innovator in HPV Vaccine Development
Introduction
Kathrin Balz is a prominent inventor based in Giessen, Germany. She has made significant contributions to the field of immunology, particularly in the development of vaccines against human papillomavirus (HPV). Her innovative work has the potential to impact public health by providing effective solutions for HPV-related infections.
Latest Patents
Kathrin Balz holds a patent for a cutaneous papilloma virus vaccine. The invention relates to an immunogenic polypeptide that comprises a multitude of papillomavirus (PV) L2 N-terminal peptides corresponding to amino acids 20 to 50 of the L2 polypeptide of HPV16. This immunogenic polypeptide is designed for use in medicine and vaccination against cutaneous HPV infection and/or mucosal HPV infection. Additionally, the patent includes a polynucleotide encoding the immunogenic polypeptide, as well as vectors, host cells, and methods for producing related antibodies.
Career Highlights
Kathrin Balz is affiliated with the Deutsches Krebsforschungszentrum, where she conducts her research and development work. Her dedication to advancing medical science is evident through her innovative contributions to vaccine technology.
Collaborations
Kathrin has collaborated with notable colleagues, including Martin Müller and Xueer Zhao. These partnerships have enhanced her research efforts and contributed to the success of her projects.
Conclusion
Kathrin Balz is a trailblazer in the field of HPV vaccine development, with her patent representing a significant advancement in immunology. Her work not only showcases her expertise but also holds promise for improving health outcomes related to HPV infections.